Literature DB >> 25087231

ERAP1 functions override the intrinsic selection of specific antigens as immunodominant peptides, thereby altering the potency of antigen-specific cytolytic and effector memory T-cell responses.

David P W Rastall1, Yasser A Aldhamen1, Sergey S Seregin1, Sarah Godbehere1, Andrea Amalfitano2.   

Abstract

Endoplasmic reticulum aminopeptidase 1 (ERAP1) is a critical component of the adaptive immune system that has been shown to increase or decrease the presentation of specific peptides on MHC class I molecules. Here, we have demonstrated that ERAP1 functions are not only important during the presentation of antigen-derived peptides, but these functions can also completely change which antigen-derived peptides ultimately become selected as immunodominant T-cell epitopes. Our results suggest that ERAP1 may do this by destroying epitopes that would otherwise become immunodominant in the absence of adequate ERAP1 functionality. We further establish that ERAP1-mediated influences on T-cell functions are both qualitative and quantitative, by demonstrating that loss of ERAP1 function redirects CTL killing toward a different set of antigen-derived epitopes and increases the percent of antigen-specific memory T cells elicited by antigen exposure. As a result, our studies suggest that normal ERAP1 activity can act to suppress the numbers of T effector memory cells that respond to a given antigen. This unique finding may shed light on why certain ERAP1 single nucleotide polymorphisms are associated with several autoimmune diseases, for example, by significantly altering the robustness and quality of CD8+ T-cell memory responses to antigen-derived peptides. © The Japanese Society for Immunology. 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adaptive immune responses; antigen presentation; endoplasmic reticulum aminopeptidase-1; memory T-cells

Mesh:

Substances:

Year:  2014        PMID: 25087231      PMCID: PMC4574741          DOI: 10.1093/intimm/dxu078

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  46 in total

1.  Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells.

Authors:  Nicolas Blanchard; Takayuki Kanaseki; Hernando Escobar; Frédéric Delebecque; Niranjana A Nagarajan; Eduardo Reyes-Vargas; David K Crockett; David H Raulet; Julio C Delgado; Nilabh Shastri
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

Review 2.  Proteases in MHC class I presentation and cross-presentation.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Lianjun Shen
Journal:  J Immunol       Date:  2010-01-01       Impact factor: 5.422

3.  Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens.

Authors:  Yasser A Aldhamen; Daniel M Appledorn; Sergey S Seregin; Chyong-jy J Liu; Nathaniel J Schuldt; Sarah Godbehere; Andrea Amalfitano
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

Review 4.  Post-proteasomal and proteasome-independent generation of MHC class I ligands.

Authors:  Peter van Endert
Journal:  Cell Mol Life Sci       Date:  2011-03-10       Impact factor: 9.261

5.  The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum.

Authors:  Arron Hearn; Ian A York; Kenneth L Rock
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

6.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

Authors:  Amy Strange; Francesca Capon; Chris C A Spencer; Jo Knight; Michael E Weale; Michael H Allen; Anne Barton; Gavin Band; Céline Bellenguez; Judith G M Bergboer; Jenefer M Blackwell; Elvira Bramon; Suzannah J Bumpstead; Juan P Casas; Michael J Cork; Aiden Corvin; Panos Deloukas; Alexander Dilthey; Audrey Duncanson; Sarah Edkins; Xavier Estivill; Oliver Fitzgerald; Colin Freeman; Emiliano Giardina; Emma Gray; Angelika Hofer; Ulrike Hüffmeier; Sarah E Hunt; Alan D Irvine; Janusz Jankowski; Brian Kirby; Cordelia Langford; Jesús Lascorz; Joyce Leman; Stephen Leslie; Lotus Mallbris; Hugh S Markus; Christopher G Mathew; W H Irwin McLean; Ross McManus; Rotraut Mössner; Loukas Moutsianas; Asa T Naluai; Frank O Nestle; Giuseppe Novelli; Alexandros Onoufriadis; Colin N A Palmer; Carlo Perricone; Matti Pirinen; Robert Plomin; Simon C Potter; Ramon M Pujol; Anna Rautanen; Eva Riveira-Munoz; Anthony W Ryan; Wolfgang Salmhofer; Lena Samuelsson; Stephen J Sawcer; Joost Schalkwijk; Catherine H Smith; Mona Ståhle; Zhan Su; Rachid Tazi-Ahnini; Heiko Traupe; Ananth C Viswanathan; Richard B Warren; Wolfgang Weger; Katarina Wolk; Nicholas Wood; Jane Worthington; Helen S Young; Patrick L J M Zeeuwen; Adrian Hayday; A David Burden; Christopher E M Griffiths; Juha Kere; André Reis; Gilean McVean; David M Evans; Matthew A Brown; Jonathan N Barker; Leena Peltonen; Peter Donnelly; Richard C Trembath
Journal:  Nat Genet       Date:  2010-10-17       Impact factor: 38.330

7.  Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.

Authors:  David M Evans; Chris C A Spencer; Jennifer J Pointon; Zhan Su; David Harvey; Grazyna Kochan; Udo Oppermann; Udo Opperman; Alexander Dilthey; Matti Pirinen; Millicent A Stone; Louise Appleton; Loukas Moutsianas; Loukas Moutsianis; Stephen Leslie; Tom Wordsworth; Tony J Kenna; Tugce Karaderi; Gethin P Thomas; Michael M Ward; Michael H Weisman; Claire Farrar; Linda A Bradbury; Patrick Danoy; Robert D Inman; Walter Maksymowych; Dafna Gladman; Proton Rahman; Ann Morgan; Helena Marzo-Ortega; Paul Bowness; Karl Gaffney; J S Hill Gaston; Malcolm Smith; Jacome Bruges-Armas; Ana-Rita Couto; Rosa Sorrentino; Fabiana Paladini; Manuel A Ferreira; Huji Xu; Yu Liu; Lei Jiang; Carlos Lopez-Larrea; Roberto Díaz-Peña; Antonio López-Vázquez; Tetyana Zayats; Gavin Band; Céline Bellenguez; Hannah Blackburn; Jenefer M Blackwell; Elvira Bramon; Suzannah J Bumpstead; Juan P Casas; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Serge Dronov; Audrey Duncanson; Sarah Edkins; Colin Freeman; Matthew Gillman; Emma Gray; Rhian Gwilliam; Naomi Hammond; Sarah E Hunt; Janusz Jankowski; Alagurevathi Jayakumar; Cordelia Langford; Jennifer Liddle; Hugh S Markus; Christopher G Mathew; Owen T McCann; Mark I McCarthy; Colin N A Palmer; Leena Peltonen; Robert Plomin; Simon C Potter; Anna Rautanen; Radhi Ravindrarajah; Michelle Ricketts; Nilesh Samani; Stephen J Sawcer; Amy Strange; Richard C Trembath; Ananth C Viswanathan; Matthew Waller; Paul Weston; Pamela Whittaker; Sara Widaa; Nicholas W Wood; Gilean McVean; John D Reveille; B Paul Wordsworth; Matthew A Brown; Peter Donnelly
Journal:  Nat Genet       Date:  2011-07-10       Impact factor: 38.330

8.  Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study.

Authors:  Fuu-Jen Tsai; Yi-Ching Lee; Jeng-Sheng Chang; Li-Min Huang; Fu-Yuan Huang; Nan-Chang Chiu; Ming-Ren Chen; Hsin Chi; Yann-Jinn Lee; Li-Ching Chang; Yi-Min Liu; Hsiang-Hua Wang; Chien-Hsiun Chen; Yuan-Tsong Chen; Jer-Yuarn Wu
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

9.  Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.

Authors:  Scott G Hansen; Julia C Ford; Matthew S Lewis; Abigail B Ventura; Colette M Hughes; Lia Coyne-Johnson; Nathan Whizin; Kelli Oswald; Rebecca Shoemaker; Tonya Swanson; Alfred W Legasse; Maria J Chiuchiolo; Christopher L Parks; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Michael Piatak; Jeffrey D Lifson; Louis J Picker
Journal:  Nature       Date:  2011-05-11       Impact factor: 49.962

10.  A functional variant in ERAP1 predisposes to multiple sclerosis.

Authors:  Franca Rosa Guerini; Rachele Cagliani; Diego Forni; Cristina Agliardi; Domenico Caputo; Andrea Cassinotti; Daniela Galimberti; Chiara Fenoglio; Mara Biasin; Rosanna Asselta; Elio Scarpini; Giacomo P Comi; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

View more
  8 in total

1.  Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Despoina Koumantou; Eilon Barnea; Adrian Martin-Esteban; Zachary Maben; Athanasios Papakyriakou; Anastasia Mpakali; Paraskevi Kokkala; Harris Pratsinis; Dimitris Georgiadis; Lawrence J Stern; Arie Admon; Efstratios Stratikos
Journal:  Cancer Immunol Immunother       Date:  2019-06-20       Impact factor: 6.968

2.  Mice expressing human ERAP1 variants associated with ankylosing spondylitis have altered T-cell repertoires and NK cell functions, as well as increased in utero and perinatal mortality.

Authors:  David P W Rastall; Fadel S Alyaquob; Patrick O'Connell; Yuliya Pepelyayeva; Douglas Peters; Sarah Godbehere-Roosa; Cristiane Pereira-Hicks; Yasser A Aldhamen; Andrea Amalfitano
Journal:  Int Immunol       Date:  2017-06-01       Impact factor: 4.823

3.  Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2.

Authors:  Anastasia Mpakali; Petros Giastas; Nikolas Mathioudakis; Irene M Mavridis; Emmanuel Saridakis; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

4.  Long-term, high-level hepatic secretion of acid α-glucosidase for Pompe disease achieved in non-human primates using helper-dependent adenovirus.

Authors:  D P W Rastall; S S Seregin; Y A Aldhamen; L M Kaiser; C Mullins; A Liou; F Ing; C Pereria-Hicks; S Godbehere-Roosa; D Palmer; P Ng; A Amalfitano
Journal:  Gene Ther       Date:  2016-07-01       Impact factor: 5.250

Review 5.  A role for naturally occurring alleles of endoplasmic reticulum aminopeptidases in tumor immunity and cancer pre-disposition.

Authors:  Efstratios Stratikos; Athanasios Stamogiannos; Efthalia Zervoudi; Doriana Fruci
Journal:  Front Oncol       Date:  2014-12-19       Impact factor: 6.244

6.  ERAP1 deficient mice have reduced Type 1 regulatory T cells and develop skeletal and intestinal features of Ankylosing Spondylitis.

Authors:  Yuliya Pepelyayeva; David P W Rastall; Yasser A Aldhamen; Patrick O'Connell; Sandra Raehtz; Fadel S Alyaqoub; Maja K Blake; Ashley M Raedy; Ariana M Angarita; Abdulraouf M Abbas; Cristiane N Pereira-Hicks; Sarah G Roosa; Laura McCabe; Andrea Amalfitano
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

7.  ERAP1/ERAP2 and RUNX3 polymorphisms are not associated with ankylosing spondylitis susceptibility in Chinese Han.

Authors:  W Su; L Du; S Liu; J Deng; Q Cao; G Yuan; A Kijlstra; P Yang
Journal:  Clin Exp Immunol       Date:  2018-03-30       Impact factor: 4.330

Review 8.  Understanding the Pathogenesis of Spondyloarthritis.

Authors:  Aigul Sharip; Jeannette Kunz
Journal:  Biomolecules       Date:  2020-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.